Victory Capital Management
VTVT icon

Victory Capital Management’s vTv Therapeutics VTVT Stock Holding History

Victory Capital Management’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-68
Closed -$6K – 3285
2020
Q1 		$6K Buy
+68
New +$6.54K ﹤0.01% 3451
2019
Q4 		– Sell
-35
Closed -$2K – 3279
2019
Q3 		$2K Buy
+35
New +$1.98K ﹤0.01% 3649

Other funds holding VTVT

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Victory Capital Management's VTVT Position: Q2 2020 in Review

Victory Capital Management sold out of vTv Therapeutics (VTVT) in Q2 2020, closing a stake of 68 shares — an estimated $6K sold.

Victory Capital Management first reported a position in VTVT in Q3 2019 and held it in 2 quarters. The position peaked at $6K in Q1 2020. 39 funds tracked by Wall St. Rank hold VTVT as of Q2 2020.

  • Victory Capital Management reported no remaining vTv Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 68 vTv Therapeutics shares in Q2 2020, an estimated $6K.
  • Victory Capital Management first reported a position in vTv Therapeutics in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's vTv Therapeutics position peaked at $6K in Q1 2020.
  • 39 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.